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osting by EAbstract In this paper we have investigated the in vitro antioxidant property of two triazolo-
thiadiazoles, 6-[3-(4-ﬂuorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b]-
[1,3,4]thiadiazole (FPNT) and 6-[3-(4-chlororophenyl)-1H-pyrazol-4-yl]-3-[(phenyloxy)methyl]-
[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (CPPT) by spectrophotometric DPPH and ABTS radical
scavenging methods as well as by lipid peroxide assay. The anticancer activity along with possible
mechanism of action of triazolo-thiadiazoles in Hep G2 cells was explored using MTT assay, [3H]
thymidine assay, ﬂow cytometry and chromatin condensation studies. Both FPNT and CPPT
exhibited a dose dependent cytotoxic effect on hepatocellular carcinoma cell line, HepG2. The
IC50 value was very low for both the compounds when compared to standard drug, doxorubicin.
Incorporation of [3H] thymidine in conjunction with cell cycle analysis suggested that FPNT2474000x3206, mobile: +91
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212 D. Sunil et al.inhibited the growth of HepG2 cells. Flow cytometric studies revealed more percentage of cells in
sub-G1 phase, indicating apoptosis, which was further conﬁrmed through chromatin condensation
studies by Hoechst staining. FPNT was found to be a potent antioxidant when compared to the
standard in DPPH, ABTS radical scavenging assays and lipid peroxidation studies.
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Figure 1 Chemical structures of FPNT and CPPT. (A) 6-[3-
(4-Fluorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,
4]triazolo[3,4-b][1,3,4]thiadiazole (FPNT). (B) 6-[3-(4-Chloro-
phenyl)-1H-pyrazol-4-yl]-3-[(phenyloxy)methyl][1,2,4]triazolo[3,4-
b][1,3,4]thiadiazole (CPPT).1. Introduction
Human liver carcinoma is the ﬁfth most common cancer in the
world and is accountable for more than 600,000 deaths annu-
ally. Most of the patients with hepatocellular carcinoma die
within a year after diagnosis. At present, the treatment mainly
includes surgery and chemotherapy, but the restorative effects
of the existing chemotherapeutic drugs are not good enough
and they have many side effects. Therefore, development of
highly efﬁcient, selective and less noxious antitumor drug
remains a hot research area.
1,2,4-Triazole derivatives are an interesting class of hetero-
cycles which possess a wide range of activity, high oral avail-
ability and toxicity. Triazoles and thiadiazoles have been
reported to possess analgesic (Mathew et al., 2007), anti-
inﬂammatory (Kamotra et al., 2007), antiviral (Al-Soud
et al., 2008), antimicrobial (Demirbas et al., 2004; Swamy
et al., 2006), antifungal (Tsukuda et al., 1998; Hirpara et al.,
2003; Isloor et al., 2009), antibacterial (Vikrant et al., 2009),
antitubercular (Karthikeyan et al., 2007) and antitumor (Shiv-
arama et al., 2002) activities. Reports of compounds that con-
tain two active groups, triazole and thiadiazole in a single
molecule have rarely been studied for its anticancer activity.
Also, the presence of halogens in biologically active molecules
is shown to play a critical role in its pharmacological proper-
ties. Moreover, in vitro and in vivo data suggest that certain
antioxidants selectively hinder the growth of tumor cells,
may cause cellular differentiation, and may change the intra-
cellular redox state, thereby enhancing the effects of cytotoxic
therapy (Lamson and Brignall, 1999; Conklin, 2000, 2002). In
continuation of our earlier work on the synthesis of triazolo-
thiadiazoles (Dhanya et al., 2009), we report in this paper
the anticancer properties of two triazolo-thiadiazoles, FPNT
and CPPT in HepG2 cells, in vitro. Furthermore, various
in vitro assays were also performed to evaluate their antioxi-
dant activities.2. Materials and methods
2.1. Synthesis
The triazolo-thiadiazoles, FPNT and CPPT were synthesized
by cyclization reaction between substituted triazole and substi-
tuted pyrazole acid in phosphorous oxychloride medium as per
literature methods (Dhanya et al., 2009). Their structures were
conﬁrmed by NMR and mass spectra and elemental analysis.
The purity was checked using liquid chromatography–mass
spectrometric technique. The chemical structures of the two
compounds are given in Fig. 1. The stock solution of the com-
pounds were prepared in 10% dimethyl sulphoxide (DMSO)
solution and further diluted in phosphate buffer saline (PBS)
before use. The ﬁnal concentration of DMSO in the solution
was less than 0.1%.2.2. Anticancer studies
2.2.1. Cells and cell culture
Unless otherwise mentioned, all the chemicals used in the pres-
ent study were from Sigma–Aldrich, USA. The hepatocellular
carcinoma cell line, HepG2 was used for every study. HepG2
cell lines were purchased from National Center for Cell Sci-
ence, Pune, India. The cell line was cultured in DMEM con-
taining 10% fetal bovine serum (FBS) at 37 C in an
atmosphere containing 5% CO2.
2.2.2. MTT assay
Cytotoxic effect of FPNT and CPPT was assessed using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
assay (Mosmann, 1983; Kishore et al., 2008). Cells were seeded
in duplicates in 96-well plates at 1 · 104 cells/well. After 24 h,
the triazolo-thiadiazoles were added at a concentration of
0.0001, 0.001, 0.01 and 0.1 g/L and incubated for another
24 h. 5 · 103 mol of MTT reagent was added and incubated
for additional 4 h. The purple formazan crystals were then dis-
solved in 100 · 106 L of hydrochloric acid (0.4 N):isopropanol
(1:24). Cells grown in culture media alone and with appropriate
concentration of DMSO were used as control and vehicle con-
trol, respectively. Doxorubicin was used as the standard drug.
The optical density of each well was measured at 570 nm in
an ELISA plate reader. The results are reported in Fig. 2 as per-
centage survival of the cells when compared to that of the un-
treated control cells ± standard deviation.
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Figure 2 Cytotoxic analysis of FPNT and CPPT in HepG2 cell lines using MTT assay. DMSO acts as vehicle control. In case of control
neither the compounds nor DMSO was added. Cells were treated with 0.0001, 0.001, 0.01 and 0.1 g/L of FPNT and CPPT. The percentage
viability was calculated considering control wells as 100% and plotted with representation of error bars. (A) FPNT. (B) CPPT.
6-[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole 2132.2.3. [3H] thymidine incorporation assay
DNA synthesis was monitored by labeling cells using [3H] thy-
midine (Kavitha et al., 2009). Around 1 · 109 cells/L were
seeded in duplicates, FPNT and CPPT were added at a con-
centration of 0.001, 0.01 and 0.1 g/L and incubated for 3 h.
Cells grown in culture media with appropriate concentration
of DMSO were used as control. 18.5 · 103 Bq of [3H] thymi-
dine was added and incubated for additional 2 h. The cells
were collected by Millipore ﬁltration, washed with cold 10%
trichloro acetic acid (TCA), methanol and water. Filters were
removed into liquid scintillation vials, dried, cocktail added
and radioactivity was measured using a liquid scintillation beta
counter. Radioactivity is expressed in cpm (counts per minute),
which was proportional to the amount of [3H] thymidine incor-
porated into the DNA of cultured cells ± standard deviation,
Fig. 3.
2.2.4. Cell cycle analysis
HepG2 cells were cultured and treated with two concentra-
tions, 0.00003 and 0.00005 g/L of FPNT in duplicates for
24 h to study concentration dependent effect on the cell cycle
arrest (Kavitha et al., 2009; Ormerod et al., 1994). Control
cells were treated with 0.1% DMSO. Cells were ﬁxed in 2 ml
of 70% alcohol, centrifuged at 3000 rpm for 10 min and alco-
hol was discarded. The cells were washed in 2 ml PBS and to
the pellet 15 · 106 L of RNase was added, followed by
10 · 106 L of propidium iodide. The cells were incubated
for 1 h and subjected to ﬂow cytometry. The results were ana-[1H] thymidine assay-FPNT
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Figure 3 [3H]thymidine incorporation assay to determine effect of FP
added. The data presented is result of duplicates and error bars are inlyzed using cell quest pro software using excitation at 488 nm
laser and emission at 560/670 nm. A minimum of 10,000 cells
were acquired and histograms analyzed. The total number of
cells included in analysis was taken as 100%. The results of
ﬂow cytometry studies are represented in Fig. 4. The ﬂow
cytometry data is represented in Table 1.
2.2.5. Chromatin condensation studies (Hoechst staining)
Condensation of chromatin is usually the late event in apopto-
sis. HepG2 cells were grown in 96-well plates in duplicates and
subjected to the treatment of FPNT in two different concentra-
tions of 0.01 and 0.1 g /L and incubated for 24 h. Cells grown
in culture media with appropriate concentration of DMSO
were used as control. About 50 · 106 L of the medium was
aspirated, the same amount of diluted Hoechst dye was added
and incubated for 5 min. 50 · 106 L of the medium was re-
moved and viewed under ﬂuorescence microscope. Hoechst
dye binds at the adenine–thymine rich regions of DNA and
emits blue ﬂuorescence when excited by UV light about
350 nm. The results of chromatin condensation studies are
shown in Fig. 5.
2.3. Antioxidant studies
2.3.1. DPPH radical scavenging assay
The DPPH antioxidant assay is based on the ability of DPPH,
a stable free radical, to decolorize in the presence of antioxi-
dants. The DPPH radical contains an odd electron, which is[1H] thymidine assay-CPPT
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Figure 4 (A–C) Cell cycle analysis histograms. (A) Control (DMSO). (B) 0.00003 g/L of FPNT. (C) 0.00005 g/L of FPNT. (D) Bar
diagram showing quantiﬁcation of cells in each phase of the cell cycle on treatment with FPNT.
Table 1 The percentage of cells in each stage of cell cycle in ﬂow cytometric analysis.
Concentration M1 (% sub-G1-cells) M2 (% G1 cells) M3 (% S cells) M4 (% G2/M cells)
Control 3.57 ± 0.02 50.68 ± 2.42 32.84 ± 1.06 12.92 ± 0.27
0.00003 g/L 4.69 ± 0.07 56.41 ± 1.96 24.48 ± 0.98 14.12 ± 0.63
0.00005 g/L 9.31 ± 0.09 54.20 ± 1.37 27.53 ± 0.67 8.95 ± 0.18
Figure 5 Chromatin condensation studies (Hoechst test). Dose dependent increase in condensed apoptotic chromatin is visible on
treatment with FPNT when compared to control. (A) Control (DMSO). (B) 0.01 g /L FPNT. (C) 0.1 g/L FPNT.
214 D. Sunil et al.responsible for the absorbance at 517 nm and also for visible
deep purple color (Sreejayan and Rao, 1996; John and Steven,
1984). When DPPH accepts an electron donated by an antiox-
idant compound, the DPPH is decolorized which can be quan-
titatively measured from the changes in absorbance. Hundred
microlitre of various concentrations of FPNT was added to
respective wells of a 96-well micro plate. Equal amount ofDPPH (1,1-diphenyl-2-picryl hydrazide) was also added to
each well to make up a ﬁnal volume of 200 ll. After 20 min
incubation in the dark, the ability of FPNT to scavenge the
free radical DPPH, was measured by recording the absorbance
at 517 nm using an ELISA plate recorder. Experiment was per-
formed in triplicates and average values were considered. An
equal amount of methanol and DPPH was added to the
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Figure 6 DPPH radical scavenging activity of FPNT added to
methanol solution of DPPH. Radical scavenging activity was
measured at 517 nm as compared to standard ascorbic acid.
Values are the average of triplicate experiments.
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Figure 7 ABTS radical scavenging activity of FPNT measured
at 690 nm as compared to standard ascorbic acid. Values are the
average of triplicate experiments.
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Figure 8 In vitro lipid peroxide assay of FPNT measured at
535 nm as compared to standard curcumin. Values are the average
of triplicate experiments.
6-[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole 215control. Ascorbic acid was used as reference standard. Com-
parison of the antioxidant activity of FPNT and ascorbic acid
is shown in Fig. 6.
% Scavenging of DPPH
¼Absorbance of controlAbsorbance of test sample
Absorbance of control
 100
2.3.2. ABTS radical scavenging assay
ABTS is chemically 2,2-azino bis 3-ethyl benzo-thiazoline-6-
sulphonic acid. The reduction of this radical by FPNT is mea-
sured at 690 nm (Vaijanathappa et al., 2008). The electron
transfer capability of FPNT was studied using ABTS radical
scavenging assay. In a 96-welled microtitre plate, 40 ll of the
FPNT/ascorbic acid, 200 ll of methanol and 30 ll of ABTS
solution were added. The plate was then incubated at 37 C
for 20 min after which the absorbance was measured at
690 nm using an ELISA plate reader. Sample blank and con-
trol were also taken. The experiment was performed in tripli-
cates and average values were considered. The comparative
values of the antioxidant activity of FPNT and ascorbic acid
is depicted in Fig. 7.
% Scavenging of ABTS
¼Absorbance of controlAbsorbance of test sample
Absorbance of control
 100
2.3.3. Lipid peroxidation assay
Malonaldehyde, formed from breakdown of polyunsaturated
fatty acids, serves as a convenient index for determining the ex-
tent of peroxidation reaction (Okhawa et al., 1979). Malonal-
dehyde reacts with thiobarbituric acid to form TBARS, a red
chromogen, which is measured at 535 nm. Albino rats (180–
200 g) of either sex were used for the study. After decapitation,
the brain was removed carefully. The tissue was immediately
weighed and homogenated with cold 1.15% potassium chlo-ride solution to make 10% homogenate. This homogenate
was immediately used for in vitro lipid peroxidation study. Li-
pid peroxidation was initiated by adding 1 ml of 100 lM fer-
rous sulphate to a 0.5 ml mixture containing rat brain
homogenate and 1 ml of different concentrations of FPNT.
The resultant solution was incubated for 30 min and the reac-
tion was terminated by adding ice cold TBA–TCA reagent.
Further, the mixture was mixed thoroughly and heated for
15 min in boiling water bath. After cooling, the ﬂocculent pre-
cipitate was removed by centrifugation at 1000 rpm for 10 min.
The absorbance of the supernatant was measured at 535 nm.
The experiment was repeated in triplicates and the average val-
ues were measured. The same procedure was repeated with
curcumin as reference. The results of the in vitro lipid peroxi-
dation assay for FPNT and curcumin is presented in Fig. 8.
% Scavenging
¼Absorbance of controlAbsorbance of test sample
Absorbance of control
 100
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Induction of apoptosis or inhibitions of cell proliferation are
important properties associated with chemotherapeutic agents.
In our present study, we have used FPNT and CPPT to under-
stand the mechanism of its cytotoxicity. Hepatocellular carci-
noma cell lines, HepG2 cells were used exclusively for the
entire study.
3.1. Cytotoxic effect of FPNT and CPPT
To investigate the potential effects of FPNT and CPPT, their
cytotoxicity was measured after 24 h usingMTT assay. The test
showed a dose dependent cytotoxic effect of FPNT and CPPT,
their IC50 being 0.0005 and 0.006 g/L. These values were found
to be signiﬁcantly low when compared to standard drug, doxo-
rubicin with IC50 0.019 g/L. Since above study suggested that
both FPNT and CPPT affects the cell viability, we were inter-
ested to know whether they could inhibit cell division.
3.2. FPNT affects cell proliferation
One of the currently employed methods to assess cell prolifer-
ation is based on incorporation of radio labeled nucleotides
into the DNA of the dividing cells. FPNT treatment showed
a dose dependant reduced incorporation of [3H] thymidine
drastically, suggesting that it affects the cell viability by inhib-
iting cell division probably by interfering with DNA replica-
tion. However it is also possible that in addition to its effect
on cell division, FPNT could also induce apoptosis. The treat-
ment with CPPT did not show a dose dependent reduction in
cell proliferation when labeled with tritiated thymidine.
3.3. FPNT affects cell cycle proﬁle upon treatment with
appearance of sub-G1 cells
As FPNT induced a reduction in the number of viable cells in
MTT assay and also exhibited a reduction in the cell prolifer-
ation in tritiated thymidine assay, we were interested in study-
ing the cell cycle distribution by ﬂuorescence-activated cell
sorting analysis of PI-labeled cells. The histogram of DMSO
treated cells showed a standard cell cycle pattern, which in-
cluded G1 and G2/M peaks separated by S phase peak. The
sub-G1 peak showed very less percentage of dead cells
(Fig. 4A), when treated with control, DMSO. Interestingly
upon addition of FPNT, a concentration dependant change
was observed in the percentage of cells in each phase of the cell
cycle (Fig. 4B and C). There was a remarkable dose dependent
increase in the percentage of sub ploid cells in the sub-G1
phase. We could also observe more cells in the G1 phase when
compared to S and G2/M phase indicating a cell cycle arrest
probably in the G1 phase of the cell cycle allowing fewer cells
to enter into the S phase conﬁrming the results obtained in the
[3H] thymidine incorporation assay. The bar diagram quantify-
ing the percentage of cells in the different phases of the cell cy-
cle in control and treated group is shown in Fig. 4D.
3.4. FPNT induces apoptosis
Apoptosis is known to be a very important mechanism in-
volved in the anticancer effects induced by chemotherapeuticagents. The induction of apoptosis on treatment with FPNT
was evident from the concentration dependent increase in the
appearance of apoptotic fraction (sub-G1 population) cells.
To conﬁrm the action of FPNT through growth inhibition
mediated by a DNA replication defect followed by apoptosis,
chromatin condensation studies were conducted. DMSO trea-
ted wells were used as control (Fig. 5A). The presence of dose
dependent increase in condensed apoptotic chromatin in Hoe-
chst staining test conﬁrms the apoptotic action of FPNT
(Fig. 5B and C).
3.5. FPNT as a potent antioxidant
Antioxidant capacity is widely used as a parameter for medic-
inal bioactive components. The antioxidant most made known
for its potential beneﬁts to cancer patients is vitamin C (ascor-
bic acid). Antioxidant supplements may reduce the frequency
and severity of toxicity associated with anticancer therapy.
The IC50 values for FPNT and ascorbic acid for scavenging
DPPH were found to be 0.0012 and 0.0015 g/L correspond-
ingly. FPNT was found to be more potent than ascorbic acid.
FPNT was found to be more active when compared to ascor-
bic acid in ABTS assay with IC50 values being 0.0021 and
0.0023 g/L, respectively. In vitro lipid peroxidation assay also
revealed high antioxidant nature of FPNT compared to refer-
ence curcumin with IC50 values 0.0016 and 0.0015 g/L,
respectively.
4. Discussion
To explore the antiproliferative property of FPNT and CPPT,
initially hepatic cell viability was checked using MTT assay.
The results showed that the cell death caused by both the com-
pounds were concentration dependent. Also, the IC50 of both
the compounds was markedly lower than the standard drug,
doxorubicin which positively correlated to their potency. Re-
duced incorporation of tritiated thymidine indicated that
FPNT could inhibit the proliferation of cells. CPPT did not
show any dose dependent reduction in the incorporation of tri-
tium. Results based on cell cycle analysis suggested a G1 arrest
in the cell cycle. One of the most interesting observations of
cell cycle analysis was the increase in sub-G1 peak in a concen-
tration dependent manner, which suggested the presence of
apoptotic cells. Hoechst test conducted conﬁrmed the type of
cell death to be apoptotic as dose dependent increase in the
condensed apoptotic chromatin was visible under UV light.
The signiﬁcant antioxidant activity of FPNT with low IC50
values when compared to standard is clearly evident from
DPPH, ABTS free radical scavenging and in vitro lipid perox-
idation assays. As DPPH scavenging occurred at a lower con-
centration than ABTS scavenging, it may be presumed that the
antioxidant action of FPNT is primarily through the mecha-
nism of hydrogen transfer rather than electron transfer. The
in vitro lipid peroxidation assay also proved FPNT to be an
excellent antioxidant.
The ability to cross the biomembranes and bioavailability
of a compound is dependent on the lipophilic moiety attached.
The title compound has naphthyloxy methyl and pyrazole
substituents. The ﬂuorine atoms also might have added to
the potency of the compound as a ﬂuorine substituent
produces simultaneously an increase in lipophilicity, an
6-[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole 217electron attracting effect and a metabolic obstruction. In
FPNT, ﬂuorine atom in the para position could increase the
binding afﬁnity of the molecule.
5. Conclusions
The present study reveals FPNT as a potent cytotoxic com-
pound with low IC50 values compared to the standard drug
doxorubicin in MTT assay. Accumulation of cells in sub-G1
phase and chromatin condensation studies suggested induction
of apoptosis on treatment with FPNT. Also FPNT is found to
possess excellent antioxidant properties.Acknowledgements
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